Literature DB >> 10785214

Distinction between early and late ovarian hyperstimulation syndrome.

R S Mathur1, A V Akande, S D Keay, L P Hunt, J M Jenkins.   

Abstract

OBJECTIVE: To compare patient and cycle characteristics among three study groups: early ovarian hyperstimulation syndrome (OHSS), late OHSS, and non-OHSS.
DESIGN: Prospective observational study.
SETTING: University assisted conception service. PATIENT(S): Women undergoing in vitro fertilization, intracytoplasmic sperm injection or gamete intrafallopian transfer treatment at Bristol University In Vitro Fertilization Service between January 1, 1995, and December 31, 1998. INTERVENTION: None. MAIN OUTCOME MEASURE(S): Patient age, prevalence of polycystic ovaries, gonadotropin requirement, peak serum estradiol (E(2)) concentration, number of oocytes retrieved, clinical pregnancy rate, number of gestation sacs, and severity of OHSS. RESULT(S): Women with early OHSS had significantly higher serum E(2) levels and lower gonadotropin requirements than did the other groups. Cycles with either early or late OHSS had significantly more oocytes collected than those without OHSS. Serum E(2) and oocyte numbers did not accurately predict the risk of developing late OHSS. Clinical pregnancies occurred in all cycles with late OHSS, and multiple pregnancies were significantly more frequent in the late OHSS group than in the other groups. Late OHSS was more likely than early OHSS to be severe. CONCLUSION(S): Early OHSS relates to "excessive" preovulatory response to stimulation, whereas late OHSS depends on the occurrence of pregnancy, is likelier to be severe, and is only poorly related to preovulatory events.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10785214     DOI: 10.1016/s0015-0282(00)00492-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  42 in total

1.  What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study.

Authors:  Theoni B Tarlatzi; Christos A Venetis; Fabienne Devreker; Yvon Englert; Anne Delbaere
Journal:  J Assist Reprod Genet       Date:  2017-07-14       Impact factor: 3.412

2.  Could pretreatment with oral contraceptives before pituitary down regulation reduce the incidence of ovarian hyperstimulation syndrome in the IVF/ICSI procedure?

Authors:  Lan Wang; Yiqing Zhao; Xiyuan Dong; Kai Huang; Rui Wang; Licheng Ji; Ya Wang; Hanwang Zhang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 3.  Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.

Authors:  Ali Abbara; Sophie A Clarke; Waljit S Dhillo
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

4.  Assessing the Usefulness of Severity Markers in Women with Ovarian Hyperstimulation Syndrome.

Authors:  Aleksei Petrovich Petrenko; Camil Castelo-Branco; Dimitry Vasilevich Marshalov; Alexander Valerievich Kuligin; Efim Munevich Shifman; Elena Sergeevna Nesnova
Journal:  Reprod Sci       Date:  2020-10-15       Impact factor: 3.060

5.  Micro-dose hCG as luteal phase support without exogenous progesterone administration: mathematical modelling of the hCG concentration in circulation and initial clinical experience.

Authors:  C Yding Andersen; R Fischer; V Giorgione; Thomas W Kelsey
Journal:  J Assist Reprod Genet       Date:  2016-07-22       Impact factor: 3.412

6.  Possible involvement of single nucleotide polymorphisms in anti-Müllerian hormone signaling pathway in the pathogenesis of early OHSS in Han Chinese women.

Authors:  Lan Wang; Hemei Li; Jihui Ai; Hanwang Zhang; Yiqing Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 7.  Safety of drugs used in assisted reproduction techniques.

Authors:  Talha Al-Shawaf; Ariel Zosmer; Martha Dirnfeld; Gedis Grudzinskas
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 8.  The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome.

Authors:  Lisa C Grossman; Konstantinos G Michalakis; Hyacinth Browne; Mark D Payson; James H Segars
Journal:  Fertil Steril       Date:  2010-09       Impact factor: 7.329

9.  The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial.

Authors:  Cristiano Busso; Manuel Fernández-Sánchez; Juan Antonio García-Velasco; José Landeras; Augustín Ballesteros; Elkin Muñoz; Sandra González; Carlos Simón; Joan-Carles Arce; Antonio Pellicer
Journal:  Hum Reprod       Date:  2010-02-06       Impact factor: 6.918

10.  GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone.

Authors:  Kathleen E O'Neill; Suneeta Senapati; Ivy Maina; Clarisa Gracia; Anuja Dokras
Journal:  J Assist Reprod Genet       Date:  2016-06-27       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.